Suchergebnisse - "Bonora, Stefano"

PubPharm (9)

1

Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity

enthalten in: Antiviral therapy | 2020

von Trunfio, M. | Salvador, E. | Gaviraghi, A. | +10

2

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment

enthalten in: Antiviral therapy | 2018

von Bigliano, P. | Calcagno, A. | Lucchini, A. | +7

3

Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia

enthalten in: Antiviral therapy | 2017

von Motta, I. | Allice, T. | Romito, A. | +7

4

Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis

enthalten in: Antiviral therapy | 2016

von Trentalange, A. | Calcagno, A. | Ghisetti, V. | +4

5

Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS

enthalten in: Antiviral therapy | 2015

von Trentalange, A. | Calcagno, A. | Raviolo, S. | +5

6

Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients

enthalten in: Antiviral therapy | 2011

von Bonora, S. | Gonzalez de Requena, D. | D'Avolio, A. | +7

7

Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART

enthalten in: Antiviral therapy | 2011

von Nicastri, E. | Tommasi, C. | Abbate, I. | +12

8

Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients

enthalten in: Antiviral therapy | 2007

von Waters, L. | Moyle, G. | Bonora, S. | +8

9

Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients

enthalten in: Antiviral therapy | 2006

von Antinori, A. | Trotta, M. | Nasta, P. | +12

1
[1]